Takeda Pharmaceutical Company Limited
HDAC6 inhibitory heterocyclic compound

Abstract:

The present invention provides a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of central nervous system diseases including neurodegenerative disease, and the like, and a medicament comprising the compound. The present invention relates to a compound represented by the formula (I): ##STR00001## wherein each symbol is as defined in the specification, or a salt thereof.